2018-2023 Global Diabetes Devices Consumption Market Report

payment-methods.png
Secure Payment Methods

Diabetes Devices adopts the method of data collection and analysis of diabetes care for patients with diabetes make reasonable prediction and control of diseases

As living standards improve, an increasing obesity, the equipment has improved people’s living habits, disease control effect, is becoming more and more important

Over the next five years, LPI(LP Information) projects that Diabetes Devices will register a 5.9% CAGR in terms of revenue, reach US$ 30700 million by 2023, from US$ 21800 million in 2017.

Global Diabetes Devices Consumption market is anticipated to grow at a CAGR of XX% by 2023, according to a new report published by ResearchVector Inc. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography (North America, Europe, Asia-Pacific, MEA and South America).

The Global Market for Diabetes Devices Consumption to 2023 offers detailed coverage of guanidine Diabetes Devices Consumption industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading Diabetes Devices Consumption producers to provide exhaustive coverage of the guanidine carbonate.

This research report includes following contents:

  • Diabetes Devices Consumption Product details, including pictures and technical specifications
  • Diabetes Devices Consumption manufacturers, distributors and channels
  • Major players present in the Diabetes Devices Consumption
  • Information on competitor market shares, revenue, unit sales etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

Key vendors:

  • Becton
  • Dickinson and Company
  • Roche Diagnostics Ltd.
  • Johnson&Johnson
  • Bayer AG
  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • Ypsomed AG
  • Novo Nordisk A/S
  • Medtronic plc
  • ARKRAY Inc.
  • Terumo Corporation
  • Dexcom, Inc.
  • Sanofi

Key regions:

United States, Canada, Mexico, Brazil, China, Japan, Korea, Southeast Asia, India, Australia, Germany, France, UK, Italy, Russia, Spain, Egypt, South Africa, Israel, Turkey, GCC Countries

Additionally, the market is segmented by the following sectors

  • Blood glucose meters
  • Lancets
  • Blood glucose testing strips
  • Continuous glucose monitoring devices
  • Insulin syringes
  • Nsulin pumps
  • Insulin pens and injection
  • Segmentation by application:
  • Hospital
  • Personal Use
  • Home Use
  • Clinic

Not only this, figures covering the end user applications are also provided according to the following classification

  • Hospital
  • Personal Use
  • Home Use
  • Clinic

In summary, the report serves to study and analyse the Diabetes Devices Consumption size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Diabetes Devices Consumption, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyse and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

  • 2018-2023 Global Diabetes Devices Consumption Market Report
  • 1 Scope of the Report
    • 1.1 Market Introduction
    • 1.2 Research Objectives
    • 1.3 Years Considered
    • 1.4 Market Research Methodology
    • 1.5 Economic Indicators
    • 1.6 Currency Considered
  • 2 Executive Summary
    • 2.1 World Market Overview
      • 2.1.1 Global Diabetes Devices Consumption 2013-2023
      • 2.1.2 Diabetes Devices Consumption CAGR by Region
    • 2.2 Diabetes Devices Segment by Type
      • 2.2.1 Blood glucose meters
      • 2.2.2 Lancets
      • 2.2.3 Blood glucose testing strips
      • 2.2.4 Continuous glucose monitoring devices
      • 2.2.5 Insulin syringes
      • 2.2.6 Nsulin pumps
      • 2.2.7 Insulin pens and injection
    • 2.3 Diabetes Devices Consumption by Type
      • 2.3.1 Global Diabetes Devices Consumption Market Share by Type (2013-2018)
      • 2.3.2 Global Diabetes Devices Revenue and Market Share by Type (2013-2018)
      • 2.3.3 Global Diabetes Devices Sale Price by Type (2013-2018)
    • 2.4 Diabetes Devices Segment by Application
      • 2.4.1 Hospital
      • 2.4.2 Personal Use
      • 2.4.3 Home Use
      • 2.4.4 Clinic
    • 2.5 Diabetes Devices Consumption by Application
      • 2.5.1 Global Diabetes Devices Consumption Market Share by Application (2013-2018)
      • 2.5.2 Global Diabetes Devices Value and Market Share by Application (2013-2018)
      • 2.5.3 Global Diabetes Devices Sale Price by Application (2013-2018)
  • 3 Global Diabetes Devices by Players
    • 3.1 Global Diabetes Devices Sales Market Share by Players
      • 3.1.1 Global Diabetes Devices Sales by Players (2016-2018)
      • 3.1.2 Global Diabetes Devices Sales Market Share by Players (2016-2018)
    • 3.2 Global Diabetes Devices Revenue Market Share by Players
      • 3.2.1 Global Diabetes Devices Revenue by Players (2016-2018)
      • 3.2.2 Global Diabetes Devices Revenue Market Share by Players (2016-2018)
    • 3.3 Global Diabetes Devices Sale Price by Players
    • 3.4 Global Diabetes Devices Manufacturing Base Distribution, Sales Area, Product Types by Players
      • 3.4.1 Global Diabetes Devices Manufacturing Base Distribution and Sales Area by Players
      • 3.4.2 Players Diabetes Devices Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
    • 3.6 New Products and Potential Entrants
    • 3.7 Mergers & Acquisitions, Expansion
  • 4 Diabetes Devices by Regions
    • 4.1 Diabetes Devices by Regions
      • 4.1.1 Global Diabetes Devices Consumption by Regions
      • 4.1.2 Global Diabetes Devices Value by Regions
    • 4.2 Americas Diabetes Devices Consumption Growth
    • 4.3 APAC Diabetes Devices Consumption Growth
    • 4.4 Europe Diabetes Devices Consumption Growth
    • 4.5 Middle East & Africa Diabetes Devices Consumption Growth
  • 5 Americas
    • 5.1 Americas Diabetes Devices Consumption by Countries
      • 5.1.1 Americas Diabetes Devices Consumption by Countries (2013-2018)
      • 5.1.2 Americas Diabetes Devices Value by Countries (2013-2018)
    • 5.2 Americas Diabetes Devices Consumption by Type
    • 5.3 Americas Diabetes Devices Consumption by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Key Economic Indicators of Few Americas Countries
  • 6 APAC
  • 6.1 APAC Diabetes Devices Consumption by Countries
      • 6.1.1 APAC Diabetes Devices Consumption by Countries (2013-2018)
      • 6.1.2 APAC Diabetes Devices Value by Countries (2013-2018)
    • 6.2 APAC Diabetes Devices Consumption by Type
    • 6.3 APAC Diabetes Devices Consumption by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 Key Economic Indicators of Few APAC Countries
  • 7 Europe
    • 7.1 Europe Diabetes Devices by Countries
      • 7.1.1 Europe Diabetes Devices Consumption by Countries (2013-2018)
      • 7.1.2 Europe Diabetes Devices Value by Countries (2013-2018)
    • 7.2 Europe Diabetes Devices Consumption by Type
    • 7.3 Europe Diabetes Devices Consumption by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
    • 7.9 Spain
    • 7.10 Key Economic Indicators of Few Europe Countries
  • 8 Middle East & Africa
    • 8.1 Middle East & Africa Diabetes Devices by Countries
      • 8.1.1 Middle East & Africa Diabetes Devices Consumption by Countries (2013-2018)
      • 8.1.2 Middle East & Africa Diabetes Devices Value by Countries (2013-2018)
    • 8.2 Middle East & Africa Diabetes Devices Consumption by Type
    • 8.3 Middle East & Africa Diabetes Devices Consumption by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
    • 9.1 Market Drivers and Impact
      • 9.1.1 Growing Demand from Key Regions
      • 9.1.2 Growing Demand from Key Applications and Potential Industries
    • 9.2 Market Challenges and Impact
    • 9.3 Market Trends
  • 10 Marketing, Distributors and Customer
    • 10.1 Sales Channel
      • 10.1.1 Direct Marketing
      • 10.1.2 Indirect Marketing
    • 10.2 Diabetes Devices Distributors
    • 10.3 Diabetes Devices Customer
  • 11 Global Diabetes Devices Market Forecast
    • 11.1 Global Diabetes Devices Consumption Forecast (2018-2023)
    • 11.2 Global Diabetes Devices Forecast by Regions
      • 11.2.1 Global Diabetes Devices Forecast by Regions (2018-2023)
      • 11.2.2 Global Diabetes Devices Value Forecast by Regions (2018-2023)
      • 11.2.3 Americas Consumption Forecast
      • 11.2.4 APAC Consumption Forecast
      • 11.2.5 Europe Consumption Forecast
      • 11.2.6 Middle East & Africa Consumption Forecast
    • 11.3 Americas Forecast by Countries
      • 11.3.1 United States Market Forecast
      • 11.3.2 Canada Market Forecast
      • 11.3.3 Mexico Market Forecast
      • 11.3.4 Brazil Market Forecast
    • 11.4 APAC Forecast by Countries
      • 11.4.1 China Market Forecast
      • 11.4.2 Japan Market Forecast
      • 11.4.3 Korea Market Forecast
      • 11.4.4 Southeast Asia Market Forecast
      • 11.4.5 India Market Forecast
      • 11.4.6 Australia Market Forecast
    • 11.5 Europe Forecast by Countries
      • 11.5.1 Germany Market Forecast
      • 11.5.2 France Market Forecast
      • 11.5.3 UK Market Forecast
      • 11.5.4 Italy Market Forecast
      • 11.5.5 Russia Market Forecast
      • 11.5.6 Spain Market Forecast
    • 11.6 Middle East & Africa Forecast by Countries
      • 11.6.1 Egypt Market Forecast
      • 11.6.2 South Africa Market Forecast
      • 11.6.3 Israel Market Forecast
      • 11.6.4 Turkey Market Forecast
      • 11.6.5 GCC Countries Market Forecast
    • 11.7 Global Diabetes Devices Forecast by Type
    • 11.8 Global Diabetes Devices Forecast by Application
  • 12 Key Players Analysis
    • 12.1 Becton
      • 12.1.1 Company Details
      • 12.1.2 Diabetes Devices Product Offered
      • 12.1.3 Becton Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
      • 12.1.4 Main Business Overview
      • 12.1.5 Becton News
    • 12.2 Dickinson and Company
      • 12.2.1 Company Details
      • 12.2.2 Diabetes Devices Product Offered
      • 12.2.3 Dickinson and Company Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
      • 12.2.4 Main Business Overview
      • 12.2.5 Dickinson and Company News
    • 12.3 Roche Diagnostics Ltd.
      • 12.3.1 Company Details
      • 12.3.2 Diabetes Devices Product Offered
      • 12.3.3 Roche Diagnostics Ltd. Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
      • 12.3.4 Main Business Overview
      • 12.3.5 Roche Diagnostics Ltd. News
    • 12.4 Johnson&Johnson
      • 12.4.1 Company Details
      • 12.4.2 Diabetes Devices Product Offered
      • 12.4.3 Johnson&Johnson Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
      • 12.4.4 Main Business Overview
      • 12.4.5 Johnson&Johnson News
    • 12.5 Bayer AG
      • 12.5.1 Company Details
      • 12.5.2 Diabetes Devices Product Offered
      • 12.5.3 Bayer AG Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
      • 12.5.4 Main Business Overview
      • 12.5.5 Bayer AG News
    • 12.6 Abbott Laboratories
      • 12.6.1 Company Details
      • 12.6.2 Diabetes Devices Product Offered
      • 12.6.3 Abbott Laboratories Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
      • 12.6.4 Main Business Overview
      • 12.6.5 Abbott Laboratories News
    • 12.7 Acon Laboratories, Inc.
      • 12.7.1 Company Details
      • 12.7.2 Diabetes Devices Product Offered
      • 12.7.3 Acon Laboratories, Inc. Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
      • 12.7.4 Main Business Overview
      • 12.7.5 Acon Laboratories, Inc. News
    • 12.8 Ypsomed AG
      • 12.8.1 Company Details
      • 12.8.2 Diabetes Devices Product Offered
      • 12.8.3 Ypsomed AG Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
      • 12.8.4 Main Business Overview
      • 12.8.5 Ypsomed AG News
    • 12.9 Novo Nordisk A/S
      • 12.9.1 Company Details
      • 12.9.2 Diabetes Devices Product Offered
      • 12.9.3 Novo Nordisk A/S Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
      • 12.9.4 Main Business Overview
      • 12.9.5 Novo Nordisk A/S News
    • 12.10 Medtronic plc
      • 12.10.1 Company Details
      • 12.10.2 Diabetes Devices Product Offered
      • 12.10.3 Medtronic plc Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
      • 12.10.4 Main Business Overview
      • 12.10.5 Medtronic plc News
    • 12.11 ARKRAY Inc.
    • 12.12 Terumo Corporation
    • 12.13 Dexcom, Inc.
    • 12.14 Sanofi
  • 13 Research Findings and Conclusion

Request a FREE Sample


Our Happy Customers

Request a FREE Sample